These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5614247)

  • 1. [Report on the clinical trial with lamuran (II)].
    Steinorth G
    Med Welt; 1967 Sep; 36():2110-5. PubMed ID: 5614247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Report on the clinical testing of Lamuran (I)].
    Steinorth G
    Med Welt; 1967 Sep; 35():2025-32 contd. PubMed ID: 5595993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modification of cerebrovascular diseases through the oral administration of raubasine].
    Klein K; Grübl M
    Wien Med Wochenschr; 1974 Jun; 124(23):360-4. PubMed ID: 4599577
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with Rauwolfia alkaloid raubasin (Lamuran) in arterial, venous and lymphatic circulation disorders].
    Brembach H
    Med Welt; 1970 Feb; 6():240-3. PubMed ID: 5524036
    [No Abstract]   [Full Text] [Related]  

  • 7. [The management of ocular circulatory disturbances with lamuran].
    Genée E
    Klin Monbl Augenheilkd; 1969 Dec; 155(6):850-4. PubMed ID: 4312485
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of intravenously injected Raubasin on foot blood supply in patients with arterial blood circulation disorders of the lower limbs].
    Mahler F; Bollinger A
    Schweiz Rundsch Med Prax; 1970 Jan; 59(3):97-102. PubMed ID: 5518705
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the effects of intravenous administration of a synthetic adrenaline derivative of 1-(4-oxy-phenyl)-1-oxy-2-N-butylamino-ethane sulphate in central and peripheral vascular diseases].
    Grosso F; Riva F
    Minerva Cardioangiol; 1973 May; 21(5):375-80. PubMed ID: 4145542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
    Hamming JJ; van der Drift JH
    Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of Iskedyl in otoneurologic ischemia].
    Duchamps B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):649-53. PubMed ID: 4280429
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of disodium flavodate in circulatory insufficiencies].
    Roussel J
    Phlebologie; 1972; 25(1):83-8. PubMed ID: 5044962
    [No Abstract]   [Full Text] [Related]  

  • 13. Papaverine for cerebral and other vascular disorders.
    Med Lett Drugs Ther; 1970 Mar; 12(6):26-7. PubMed ID: 5510015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical action in vascular pathology of the limbs, of an original association of raubasine and 711 SE].
    Bouret G; Coget JM; Merlen JF; Warembourg H
    Lille Med; 1970 Mar; 15(3 Suppl 2):440-3. PubMed ID: 5421804
    [No Abstract]   [Full Text] [Related]  

  • 15. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of high doses of raubasine on the rehabilitation of patients with cerebrovascular disorders].
    Fontaine C
    Sem Hop; 1968 Mar; 44(12):806-9. PubMed ID: 4300527
    [No Abstract]   [Full Text] [Related]  

  • 17. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases].
    Sforza M; Perelli-Ercolini M
    Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109
    [No Abstract]   [Full Text] [Related]  

  • 18. [Harmful effects of vasodilator therapy].
    Bartolo M; Ortisi U
    Minerva Med; 1971 Feb; 62(16):724-9. PubMed ID: 5549393
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebrosclerosis, motor recovery and mental disorders].
    Niquet G
    Lille Med; 1972 Feb; 17():Suppl 2:187-90. PubMed ID: 5034401
    [No Abstract]   [Full Text] [Related]  

  • 20. [Raubasine in arterial pathology of the extremities].
    Perrin M
    Lyon Med; 1965 May; 213(21):1585-90. PubMed ID: 5828799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.